Immunogenicity and safety of a third dose of CoronaVac, and immune persistence of a two-dose schedule, in healthy adults: interim results from two single-centre, double-blind, randomised, placebo-controlled phase 2 clinical trials
Titel:
Immunogenicity and safety of a third dose of CoronaVac, and immune persistence of a two-dose schedule, in healthy adults: interim results from two single-centre, double-blind, randomised, placebo-controlled phase 2 clinical trials
Auteur:
Zeng, Gang Wu, Qianhui Pan, Hongxing Li, Minjie Yang, Juan Wang, Lin Wu, Zhiwei Jiang, Deyu Deng, Xiaowei Chu, Kai Zheng, Wen Wang, Lei Lu, Wanying Han, Bihua Zhao, Yuliang Zhu, Fengcai Yu, Hongjie Yin, Weidong